𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas

✍ Scribed by Tetsuro Sameshima; Kazuki Nabeshima; Bryan P. Toole; Kiyotaka Yokogami; Yasunori Okada; Tomokazu Goya; Masashi Koono; Shinichiro Wakisaka

Publisher
John Wiley and Sons
Year
2000
Tongue
French
Weight
460 KB
Volume
88
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

EMMPRIN (extracellular matrix metalloproteinase inducer), also called CD147, basigin or M6 in the human, is a member of the immunoglobulin superfamily that is present on the surface of tumor cells and stimulates adjacent fibroblasts to produce matrix metalloproteinases (MMPs). In our study, we investigated expression of EMMPRIN in human normal brain and gliomas, since mouse basigin and chicken HT7, the species homologues of human EMMPRIN, are associated with neuronal interactions and normal blood-brain barrier function, respectively. EMMPRIN expression was detected in all samples of non-neoplastic brain and glioma tissues examined. However, expression levels of EMMPRIN mRNA and protein were significantly higher in gliomas than in non-neoplastic brain. Moreover, levels of mRNA expression and immunohistochemical staining correlated with tumor progression in gliomas: They were highest in the most malignant form of glioma, glioblastoma multiforme, followed by anaplastic astrocytoma and then low-grade astrocytoma. Also, immunolocalization revealed quite different distributions in non-neoplastic brain and glioma: EMMPRIN was demonstrated only in vascular endothelium in non-neoplastic regions of the brain, whereas it was present in tumor cells but not in proliferating blood vessels in malignant gliomas. These data indicate that an MMP inducer molecule EMMPRIN is differently expressed in human normal brain and gliomas and could be associated with astrocytoma progression. Possible mechanisms whereby glioma cell EMMPRIN could influence tumor progression will be discussed. Int.

πŸ“œ SIMILAR VOLUMES

Chemokine modulation of matrix metallopr
Chemokine modulation of matrix metalloproteinase and TIMP production in adult rat brain microglia and a human microglial cell line in vitro
✍ Alison K. Cross; M. Nicola Woodroofe πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 172 KB πŸ‘ 2 views

Matrix metalloproteinases (MMPs) are a family of zinc-dependent enzymes, capable of degrading proteins found in the extracellular matrix. MMPs 2 and 9 are known to be produced by microglia, the resident macrophages of the central nervous system. The control of the secretion of these proteases and th

Ciprofloxacin enhances the stimulation o
Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1Ξ² in human tendon-derived cells : A potential mechanism of fluoroquinolone-induced tendinopathy
✍ Anthony N. Corps; Rebecca L. Harrall; Valerie A. Curry; Steven A. Fenwick; Brian πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 139 KB

## Abstract ## Objective To determine whether the fluoroquinolone antibiotic ciprofloxacin, which can cause tendon pain and rupture in a proportion of treated patients, affects the expression of matrix metalloproteinases (MMPs) in human tendon‐derived cells in culture. ## Methods Cell cultures w

Regulation of matrix metalloproteinase-2
Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP
✍ Ryouichi Hamasuna; Hiroaki Kataoka; Takuzou Moriyama; Hiroshi Itoh; Motoharu Sei πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 292 KB πŸ‘ 2 views

Hepatocyte growth factor/scatter factor (HGF/SF) contributes to the malignant progression of human gliomas. We investigated the effect of HGF/SF on matrix metalloproteinase-2 (MMP-2), membrane type 1 matrix metalloproteinase (MT1-MMP) and tissue inhibitors of metalloproteinases (TIMPs), expressions

CD80 expression in an HLA-A2-positive hu
CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer
✍ Dale L. Bixby; John R. Yannelli πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 185 KB πŸ‘ 2 views

To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mix